FDA leaders say one pivotal trial, not two, should be ‘default’ for drug approvals
FDA leaders say one pivotal trial, not two, should be ‘default’ for drug approvals
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.
FDA leaders say one pivotal trial, not two, should be ‘default’ for drug approvals